Cardinal Health Bids $1.99 Bn for J&J’s CordisBy
Johnson & Johnson have announced a binding offer from Cardinal Health to acquire its Cordis business for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds from Cardinal Health plus approximately $46 million of retained net receivables. Cordis develops and manufacture products based on interventional vascular technology and had 2014 net revenues of approximately $780 million.
The acceptance period for the offer will end on May 30, 2015, unless extended, and during that time consultations with relevant works councils and trade unions are planned. If the offer is accepted, the proposed transaction would be expected to close towards the end of 2015, subject to customary closing conditions and regulatory approvals.
Source: Johnson & Johnson